Hyperion DeFi, Inc. reported significant financial developments in its latest 10-Q filing for the quarter ending June 30, 2026. The company generated revenue of approximately $357,693 for the three months ended June 30, 2026, a notable increase from zero revenue in the same period last year. For the six months ending June 30, 2026, total revenue reached $601,964, compared to just $14,720 in the prior year. The company achieved a net income of $30,950,963 for the quarter, a substantial turnaround from a net loss of $8,690,919 in the same quarter of 2025. This shift in profitability is attributed to the company's strategic focus on digital assets and staking activities.
The financial performance reflects a broader strategic pivot for Hyperion DeFi, which has wound down its operations related to the Optejet User Filled Device, a product previously under development. The company sold its associated intellectual property to Arctic Vision for a $100,000 release of indebtedness, marking a complete exit from the ophthalmic technology sector. As of June 30, 2026, Hyperion DeFi's total assets surged to $113.1 million, up from $51.8 million at the end of 2025, driven by a significant increase in digital assets, which rose to $74.1 million from $16.3 million.
Operationally, Hyperion DeFi has made strides in its digital asset strategy, with a focus on staking and validation activities on the Hyperliquid blockchain. The company reported that it had staked approximately 634,379 HYPE tokens, contributing to its revenue generation. The total number of users on the Hyperliquid platform has reached approximately 1.6 million since its inception, indicating a growing market presence. The company also reported a significant increase in its cash and cash equivalents, which rose to $9.6 million from $6.3 million at the end of 2025.
Looking ahead, Hyperion DeFi's management expressed confidence in the company's ability to sustain its operations and growth trajectory, supported by its current cash reserves and ongoing digital asset strategies. However, the company acknowledged that its financial condition remains heavily dependent on the market price and liquidity of HYPE tokens, which are subject to volatility. The company plans to continue pursuing additional capital through its at-the-market offering programs, although it cautioned that such funding may not always be available on favorable terms. Overall, Hyperion DeFi's recent financial results and strategic developments position it for potential growth in the evolving digital asset landscape.
About HYPERION DEFI, INC.
Eyenovia, Inc. develops innovative ophthalmic delivery platforms, primarily the Optejet, for precise microdosing of eye medications. Its core products include FDA-approved Mydcombi for pupil dilation and licensed clobetasol propionate for post-surgical inflammation. The company focuses on improving treatment efficacy, safety, and patient compliance through targeted, low-volume delivery systems, leveraging digital health integration and strategic licensing in ophthalmology markets.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.
View the complete official filing on the SEC website.
Read on SEC.gov